Dice Molecules Corporation is categorized under Commercial Biotechnical Research in Menlo Park, CA and active since 2013.
Dice Molecules Corporation was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact James Kevin Judice at the company’s single location by writing to 1455 Adams Court # 1610, Menlo Park, California CA 94025 or by phoning (650) 823-2656. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dice Molecules Corporation |
Contact Person: | James Kevin Judice |
Address: | 1455 Adams Court # 1610, Menlo Park, California 94025 |
Phone Number: | (650) 823-2656 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Dice Molecules Corporation was started in 2013 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact James Kevin Judice for inquiries that concern Dice Molecules Corporation by calling the company number (650) 823-2656, as your correspondence is most welcome. Additionally, the physical location of the single location of Dice Molecules Corporation can be found at the coordinates as well as the street address 1455 Adams Court # 1610 in Menlo Park, California 94025.
For its online presence, you may visit Dice Molecules Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.